• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Search results from the "OB_Rx" table for query on "021880."



Active Ingredient: LENALIDOMIDE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REVLIMID
Applicant: CELGENE
Strength: 5MG
Application Number: N021880
Product Number: 001
Approval Date: Dec 27, 2005
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: LENALIDOMIDE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REVLIMID
Applicant: CELGENE
Strength: 10MG
Application Number: N021880
Product Number: 002
Approval Date: Dec 27, 2005
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: LENALIDOMIDE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REVLIMID
Applicant: CELGENE
Strength: 15MG
Application Number: N021880
Product Number: 003
Approval Date: Jun 29, 2006
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: LENALIDOMIDE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REVLIMID
Applicant: CELGENE
Strength: 25MG
Application Number: N021880
Product Number: 004
Approval Date: Jun 29, 2006
Reference Listed Drug Yes
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: LENALIDOMIDE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REVLIMID
Applicant: CELGENE
Strength: 2.5MG
Application Number: N021880
Product Number: 005
Approval Date: Dec 21, 2011
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: LENALIDOMIDE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REVLIMID
Applicant: CELGENE
Strength: 20MG
Application Number: N021880
Product Number: 006
Approval Date: Jun 5, 2013
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through October 2014
Patent and Generic Drug Product Data Last Updated November 26, 2014

-
-